OP-04 program (Onco-Pharmakon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOP-04 program (Onco-Pharmakon)
Drug Alias NameOP-04
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOnco-Pharmakon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOnco-Pharmakon Inc
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A